Trial intelligence / Profile preview

Ketorolac vs Placebo in Cataract Surgery

NCT01542190Phase 4Completed

Sponsor
Universidade Estadual de Campinas
Start
Feb 2011
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in cystoid macular edema (CME) comparing Placebo Group with Ketorolac Group (2 arms). Primary endpoint: Angiographic Cystoid Macular Edema at 5 weeks. Started Feb 2011; status: completed.

02

Drugs

ketorolac
03

Conditions

cystoid macular edema (CME)

Beyond the preview

Go deeper on NCT01542190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01542190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call